What is aTyr Pharma's retained earnings?

aTyr Pharma (ATYR) reported retained earnings of -$616.96M in Q1 2026.

How has aTyr Pharma's retained earnings changed year-over-year?

aTyr Pharma's retained earnings decreased by 12.8% year-over-year, from -$546.93M to -$616.96M.

What is the long-term trend for aTyr Pharma's retained earnings?

Over 5 years (2020 to 2025), aTyr Pharma's retained earnings has grown at a 12.4% compound annual growth rate (CAGR), from -$338.53M to -$606.16M.

What does retained earnings mean?

Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.

aTyr Pharma ATYR Retained Earnings

Retained Earnings at other companies

Bristol-Myers SquibbBMY

$18.29B+13.5%

Merck & Co.MRK

$66.72B+0.9%

United TherapeuticsUTHR

$8.83B+17.1%

Design Therapeutics, Inc.DSGN

-$314.64M-28.5%

CytomX TherapeuticsCTMX

-$730.2M-9.3%

Vor BiopharmaVOR

-$1.37B-180%

Other financials

Income statement

See full

Revenue-—

Operating income-$11.4M+27.5%

Net income-$10.8M+27.5%

EPS (diluted)-$0.11+35.3%

Balance sheet

See full

Cash & equivalents$10.0M-3.4%

Total debt$12.3M-9.2%

Total equity$57.9M-22.8%

Total assets$79.7M-18.1%

Cash flow

See full

Operating cash flow-$12.5M+18.8%

CapEx$138.0K—

Free cash flow-$12.7M+17.9%

Valuation

See full

Market cap$54.88M-88.2%

Enterprise value$57.17M—

P/S288.8×—

Profitability

See full

Operating margin-40,856.3%+28,833pp

Net margin-39,009.5%+29,653pp

FCF margin-32,664.7%+4,018pp

Returns & leverage

See full

Return on equity-105.3%+50.6pp

Debt / equity0.2×0.0×

Current ratio5.8×-2.0×

Where this comes from

Reported directly by aTyr Pharma in its filing.

Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.

The official record: aTyr Pharma’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about aTyr Pharma's retained earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is aTyr Pharma's retained earnings?: aTyr Pharma (ATYR) reported retained earnings of -$616.96M in Q1 2026.
How has aTyr Pharma's retained earnings changed year-over-year?: aTyr Pharma's retained earnings decreased by 12.8% year-over-year, from -$546.93M to -$616.96M.
What is the long-term trend for aTyr Pharma's retained earnings?: Over 5 years (2020 to 2025), aTyr Pharma's retained earnings has grown at a 12.4% compound annual growth rate (CAGR), from -$338.53M to -$606.16M.
What does retained earnings mean?: Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.